HEADER CELL CYCLE 30-NOV-12 2M1L TITLE SOLUTION NMR STRUCTURE OF CYCLIN-DEPENDENT KINASE 2-ASSOCIATED PROTEIN TITLE 2 2 (CDK2AP2, DOC-1R) FROM HOMO SAPIENS, NORTHEAST STRUCTURAL GENOMICS TITLE 3 CONSORTIUM (NESG) TARGET HR8910C COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2-ASSOCIATED PROTEIN 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 61-126; COMPND 5 SYNONYM: CDK2-ASSOCIATED PROTEIN 2, DOC-1-RELATED PROTEIN, DOC-1R; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2AP2, DOC1R; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PMGK; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET15NANO6HT_NESG KEYWDS STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, KEYWDS 2 PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, CELL CYCLE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.ERTEKIN,H.JANJUA,E.KOHAN,R.SHASTRY,K.PEDERSON,J.H.PRESTEGARD, AUTHOR 2 G.T.MONTELIONE,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 2 14-JUN-23 2M1L 1 REMARK SEQADV REVDAT 1 09-JAN-13 2M1L 0 JRNL AUTH A.ERTEKIN,H.JANJUA,R.SHASTRY,K.PEDERSON,J.H.PRESTEGARD, JRNL AUTH 2 G.T.MONTELIONE JRNL TITL SOLUTION NMR STRUCTURE OF CDK2-ASSOCIATED PROTEIN 2 JRNL TITL 2 (CDK2AP2, DELETED IN ORAL CANCER 1 RELATED PROTEIN, DOC-1R) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3, CNS 1.3 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BRUNGER, ADAMS, CLORE, GROS, NILGES AND REMARK 3 READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE DETERMINATION OF THIS REMARK 3 SYMMETRIC HOMODIMER WAS PERFORMED ITERATIVELY USING CYANA 3.02. REMARK 3 THE 20 STRUCTURES OUT OF 100 WITH LOWEST TARGET FUNCTION WERE REMARK 3 FURTHER REFINED BY RESTRAINED MOLECULAR DYNAMICS/ENERGY REMARK 3 MINIMIZATION IN EXPLICIT WATER USING CNS 1.3. RESIDUAL DIPOLAR REMARK 3 COUPLINGS AND BACKBONE DIHEDRAL ANGLE CONSTRAINTS FOR THE REMARK 3 ORDERED REGIONS WERE APPLIED AT ALL STAGES OF THE STRUCTURE REMARK 3 DETERMINATION REMARK 4 REMARK 4 2M1L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-DEC-12. REMARK 100 THE DEPOSITION ID IS D_1000103093. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 5.0 MG/ML [U-100% 13C; U-100% REMARK 210 15N] HR8910C.003, 1 X PROTEINASE REMARK 210 INHIBITORS, 0.02 % NAN3, 10 MM REMARK 210 DTT, 5 MM CACL2, 200 MM NACL, 20 REMARK 210 MM MES PH 6.5, 5 % D2O, 95% H2O/ REMARK 210 5% D2O; 5.0 MG/ML [U-100% 13C; U- REMARK 210 100% 15N] HR8910C, 15.0 MG/ML REMARK 210 HR8910C, 0.02 % NAN3, 10 MM DTT, REMARK 210 5 MM CACL2, 200 MM NACL, 20 MM REMARK 210 MES PH 6.5, 5 % D2O, 1 X REMARK 210 PROTEINASE INHIBITORS, 95% H2O/5% REMARK 210 D2O; 0.3 MM [U-100% 15N] REMARK 210 HR8910C, 0.02 % NAN3, 10 MM DTT, REMARK 210 5 MM CACL2, 200 MM NACL, 20 MM REMARK 210 MES PH 6.5, 5 % D2O, 1 X REMARK 210 PROTEINASE INHIBITORS, 4.2 % PEG, REMARK 210 95% H2O/5% D2O; 5.0 MG/ML [U-5% REMARK 210 13C; U-100% 15N] HR8910C.005, 1 REMARK 210 X PROTEINASE INHIBITORS, 0.02 % REMARK 210 NAN3, 10 MM DTT, 5 MM CACL2, 200 REMARK 210 MM NACL, 20 MM MES PH 6.5, 5 % REMARK 210 D2O, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCO; 3D CBCA(CO)NH; 3D REMARK 210 HNCACB; 3D HBHA(CO)NH; 3D HN(CA) REMARK 210 CO; 3D 1H-13C NOESY ALIPHATIC; REMARK 210 3D 1H-15N NOESY; 3D 13C-FILTERED REMARK 210 NOESY ALIPHATIC; 2D 13C-FILTERED REMARK 210 NOESY AROMATIC; 2D 1H-13C HIGH REMARK 210 RES (L/V METHYL STEREOSPECIFIC REMARK 210 ASSIGNMENT); 3D HCCH-TOCSY; 3D REMARK 210 HCCH-COSY; 3D 1H-13C NOESY REMARK 210 AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 3.02, AUTOASSIGN 2.1, REMARK 210 NMRPIPE 2.0, TOPSPIN 2.1, PINE REMARK 210 1.0, SPARKY 3.112, TALOS+, PALES, REMARK 210 PSVS 1.4 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 61 75.47 -158.65 REMARK 500 1 ALA A 67 -74.93 -70.26 REMARK 500 1 SER A 70 26.65 -157.85 REMARK 500 1 GLN A 71 34.24 -154.87 REMARK 500 1 ALA A 124 83.05 -155.84 REMARK 500 1 ARG A 125 -67.62 -102.53 REMARK 500 1 ALA B 67 -70.81 -167.14 REMARK 500 1 ASN B 123 -84.98 -78.91 REMARK 500 2 LYS A 63 81.00 -158.77 REMARK 500 2 ALA A 67 97.26 -66.56 REMARK 500 2 GLN A 68 -156.53 -155.08 REMARK 500 2 ALA B 61 93.67 -66.61 REMARK 500 2 LYS B 63 94.91 -166.40 REMARK 500 2 PRO B 65 92.65 -61.75 REMARK 500 3 ALA A 67 91.74 -62.32 REMARK 500 3 LYS B 63 66.09 -159.78 REMARK 500 3 ALA B 67 -157.79 -142.89 REMARK 500 3 GLN B 68 93.87 -60.27 REMARK 500 3 SER B 70 105.97 -53.47 REMARK 500 3 GLN B 71 106.20 -170.49 REMARK 500 3 ALA B 124 95.71 -66.56 REMARK 500 4 MET A 60 100.50 -50.01 REMARK 500 4 ALA A 61 79.80 -169.52 REMARK 500 4 PRO A 65 84.97 -60.66 REMARK 500 4 PRO B 65 102.66 -58.83 REMARK 500 4 ALA B 67 106.68 -53.98 REMARK 500 4 GLN B 68 -54.45 -165.65 REMARK 500 4 SER B 70 -48.72 -168.15 REMARK 500 4 SER B 95 99.14 -67.29 REMARK 500 5 MET A 62 92.37 -53.54 REMARK 500 5 LYS A 63 74.34 -170.16 REMARK 500 5 SER A 70 -169.70 -118.46 REMARK 500 5 MET B 62 -147.59 -90.48 REMARK 500 5 LYS B 63 107.29 74.55 REMARK 500 5 PRO B 64 88.80 -15.16 REMARK 500 5 GLN B 68 -37.10 -161.84 REMARK 500 5 GLN B 71 16.92 57.80 REMARK 500 6 LYS A 63 61.42 -152.70 REMARK 500 6 PRO A 65 96.10 -62.91 REMARK 500 6 ALA A 67 -44.16 -151.24 REMARK 500 6 ALA B 61 45.56 -153.77 REMARK 500 6 PRO B 65 95.97 -58.97 REMARK 500 6 GLN B 68 121.87 68.77 REMARK 500 6 SER B 95 99.18 -69.78 REMARK 500 7 MET A 62 -169.95 -121.87 REMARK 500 7 LYS A 63 89.59 63.89 REMARK 500 7 ALA A 67 -77.14 -133.93 REMARK 500 7 GLN A 68 -156.16 -96.43 REMARK 500 7 MET B 60 114.01 -170.71 REMARK 500 7 ALA B 61 31.41 -143.83 REMARK 500 REMARK 500 THIS ENTRY HAS 113 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18869 RELATED DB: BMRB REMARK 900 RELATED ID: NESG-HR8910C RELATED DB: TARGETTRACK DBREF 2M1L A 61 126 UNP O75956 CDKA2_HUMAN 61 126 DBREF 2M1L B 61 126 UNP O75956 CDKA2_HUMAN 61 126 SEQADV 2M1L SER A 58 UNP O75956 EXPRESSION TAG SEQADV 2M1L HIS A 59 UNP O75956 EXPRESSION TAG SEQADV 2M1L MET A 60 UNP O75956 EXPRESSION TAG SEQADV 2M1L SER B 58 UNP O75956 EXPRESSION TAG SEQADV 2M1L HIS B 59 UNP O75956 EXPRESSION TAG SEQADV 2M1L MET B 60 UNP O75956 EXPRESSION TAG SEQRES 1 A 69 SER HIS MET ALA MET LYS PRO PRO GLY ALA GLN GLY SER SEQRES 2 A 69 GLN SER THR TYR THR ASP LEU LEU SER VAL ILE GLU GLU SEQRES 3 A 69 MET GLY LYS GLU ILE ARG PRO THR TYR ALA GLY SER LYS SEQRES 4 A 69 SER ALA MET GLU ARG LEU LYS ARG GLY ILE ILE HIS ALA SEQRES 5 A 69 ARG ALA LEU VAL ARG GLU CYS LEU ALA GLU THR GLU ARG SEQRES 6 A 69 ASN ALA ARG THR SEQRES 1 B 69 SER HIS MET ALA MET LYS PRO PRO GLY ALA GLN GLY SER SEQRES 2 B 69 GLN SER THR TYR THR ASP LEU LEU SER VAL ILE GLU GLU SEQRES 3 B 69 MET GLY LYS GLU ILE ARG PRO THR TYR ALA GLY SER LYS SEQRES 4 B 69 SER ALA MET GLU ARG LEU LYS ARG GLY ILE ILE HIS ALA SEQRES 5 B 69 ARG ALA LEU VAL ARG GLU CYS LEU ALA GLU THR GLU ARG SEQRES 6 B 69 ASN ALA ARG THR HELIX 1 1 GLN A 71 LYS A 86 1 16 HELIX 2 2 GLU A 87 ALA A 93 1 7 HELIX 3 3 SER A 95 GLU A 121 1 27 HELIX 4 4 GLN B 71 GLU B 87 1 17 HELIX 5 5 GLU B 87 ALA B 93 1 7 HELIX 6 6 SER B 95 ALA B 124 1 30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1